A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease

Twenty-one depressed patients with probable Alzheimer's disease (AD) were randomized to receive a 6-week treatment with clomipramine or placebo in a study with a double-blind crossover design. Main outcome measures were Hamilton Depression, Mini-Mental State (MMSE), and Functional Independence...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Petracca, G., Tesón, A., Chemerinski, E., Leiguarda, R., Starkstein, S.E.
Formato: JOUR
Materias:
clomipramine
tricyclic antidepressant agent
adult
aged
Alzheimer disease
article
clinical article
clinical trial
confusion
constipation
controlled clinical trial
controlled study
crossover procedure
depression
double blind procedure
drug efficacy
female
functional assessment
Hamilton scale
headache
human
male
mood
nausea
oral drug administration
priority journal
randomized controlled trial
sleep disorder
stomach pain
time
treatment outcome
tremor
vertigo
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_08950172_v8_n3_p270_Petracca
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Ejemplares similares